Bottom line
Is DXIV a good fund? The bottom line
DXIV is an actively managed international stock ETF from Dimensional.
Annual fees run 0.3% — about $30 a year on every $10,000 invested, cheaper than 90% of international stock funds we track.
It returned +38.5% over one year (as of Dec 31, 2025, per its prospectus).
With $131 million in net assets and 2,635 holdings, its largest position is Dimensional Fund Advisors Lp (3.3%) and the top 10 make up 9.5% of the portfolio.
What stands out
- Low cost: cheaper than 90% of international stock peers
- Broadly diversified (2,635 holdings)
Updated Nov 19, 2026
What DXIV invests in
The investment objective of the Dimensional International Vector Equity ETF (the International Vector Equity ETF or Portfolio) is to achieve long-term capital appreciation.
To achieve the International Vector Equity ETFs investment objective, Dimensional Fund Advisors LP (the Advisor) implements an integrated investment approach that combines research, portfolio design, portfolio management, and trading functions. As further described below, the Portfolios design emphasizes long-term drivers of expected returns identified by the Advisors research, while balancing risk through broad diversification across companies, sectors, and countries. The Advisors portfolio management and trading processes further balance those long-term drivers of expected returns with shorter-term drivers of expected returns and trading costs. The International Vector Equity ETF is designed to purchase a broad and diverse group of equity securities within a market capitalization weighted universe (e.g., the larger the company, the greater the proportion of the universe it…
From the fund's prospectus (filed Feb 27, 2026).
DXIV performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| DXIV | +38.5% | — | — |
| International Stock median | +25.5% | +6.4% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2025
What DXIV costs
On a $10,000 investment, DXIV's 0.3% expense ratio costs about $30 a year. The prospectus estimates $643 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
DXIV top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Dimensional Fund Advisors Lp | 3.29% |
| 2 | Totalenergies Se | 1.00% |
| 3 | Novartis AG | 0.79% |
| 4 | Bhp Group Limited | 0.75% |
| 5 | ASML Holding N.V. | 0.73% |
| 6 | Bayer Aktiengesellschaft | 0.61% |
| 7 | Shell Plc | 0.60% |
| 8 | Roche Holding AG | 0.60% |
| 9 | Orange Sa | 0.59% |
| 10 | Astrazeneca Plc | 0.55% |
Source: SEC Form N-PORT, period ended Jan 31, 2026
The top 10 make up 9.5% of the fund. See all top 25 holdings and asset mix →